These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2325593

  • 1. IgA nephropathy: a long-term progressive study.
    Orłowski T, Górski A, Rancewicz Z, Morzycka-Michalik M, Smogorzewski M, Małdyk M, Lao M, Szczesny-Nowicka B.
    Miner Electrolyte Metab; 1990; 16(1):54-6. PubMed ID: 2325593
    [Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

  • 3. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 4. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D, Ahuja M, Shortland JR, Brown CB.
    Nephrol Dial Transplant; 1995 Sep; 10(7):1173-81. PubMed ID: 7478120
    [Abstract] [Full Text] [Related]

  • 5. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V, Tesar V, Zabka J, Rychlík I, Merta M, Jirsa M, Stejskalová A, Stejskal J.
    Cas Lek Cesk; 1996 Dec 18; 135(24):803-6. PubMed ID: 9072300
    [Abstract] [Full Text] [Related]

  • 6. [A cumulative renal survival analysis of 495 cases of IgA nephropathy].
    Qin Y, Li XW, Li H, Duan L, Li Y.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr 18; 26(2):160-3. PubMed ID: 15171553
    [Abstract] [Full Text] [Related]

  • 7. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep 18; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 8. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.
    J Med Assoc Thai; 2004 Feb 18; 87(2):143-9. PubMed ID: 15061297
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M.
    Clin Nephrol; 2000 Jan 18; 53(1):1-9. PubMed ID: 10661476
    [Abstract] [Full Text] [Related]

  • 10. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
    Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH.
    Clin Nephrol; 1991 Aug 18; 36(2):60-6. PubMed ID: 1934661
    [Abstract] [Full Text] [Related]

  • 11. Clinical effect of dipyridamole in patients with IgA nephropathy.
    Yagame M, Tomino Y, Miura M, Suga T, Endoh M, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1986 Nov 18; 11(5):329-33. PubMed ID: 2960035
    [Abstract] [Full Text] [Related]

  • 12. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y, Okada H, Saruta T, Suzuki H.
    Clin Nephrol; 2000 Nov 18; 54(5):360-5. PubMed ID: 11105796
    [Abstract] [Full Text] [Related]

  • 13. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
    Locatelli F, Pozzi C, Del Vecchio L, Andrulli S, Pani A, Fogazzi G, Altieri P, Ponticelli C.
    J Nephrol; 1999 Nov 18; 12(5):308-11. PubMed ID: 10630693
    [Abstract] [Full Text] [Related]

  • 14. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF, Júnior GB, Barros FA, Sousa DC, Franco LM, Patrocínio RM.
    Invest Clin; 2006 Dec 18; 47(4):405-11. PubMed ID: 17176908
    [Abstract] [Full Text] [Related]

  • 15. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul 18; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 16. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 18; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 17. The impact of sex in primary glomerulonephritis.
    Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
    Nephrol Dial Transplant; 2008 Jul 18; 23(7):2247-53. PubMed ID: 18182409
    [Abstract] [Full Text] [Related]

  • 18. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Jul 18; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 19. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y, Fujii K, Hiki Y, Tateno S.
    Q J Med; 1986 Oct 18; 61(234):935-43. PubMed ID: 3628707
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep 18; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.